Literature DB >> 4064275

Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias.

D S Poll, F E Marchlinski, R A Falcone, M E Josephson, M B Simson.   

Abstract

We assessed whether signal-averaged electrocardiography could identify patients with sustained ventricular arrhythmias in 41 patients with non-ischemic cardiomyopathy. Twelve of these patients presented with sustained ventricular arrhythmia and 29 patients had no history of sustained ventricular arrhythmias. The mean ejection fractions in the groups were 30 +/- 9% and 24 +/- 9%, respectively. Results were compared with signal-averaged electrocardiograms in 55 normal individuals. The filtered QRS duration was longest in patients with sustained ventricular arrhythmias (130.2 +/- 19.5 vs 105.0 +/- 13.1 msec in the group without sustained ventricular arrhythmia, p less than .001 and 95.9 +/- 9.1 in the normal group, p less than .001). The voltage in the last 40 msec of the filtered QRS was lower in the sustained ventricular arrhythmia group (11.3 +/- 9.3 microV) than the group without sustained ventricular arrhythmia (53.5 +/- 28.3 microV; p less than .001) or the normal group (53.7 +/- 25.2 microV; p less than .001). Eighty-three percent of patients in the sustained ventricular arrhythmia group had an abnormal signal-averaged electrocardiogram characterized by both a long filtered QRS duration and a late potential of low voltage level; only 2% of normal subjects and 14% of patients without sustained ventricular arrhythmias had an abnormal signal-averaged electrocardiogram. The signal-averaged electrocardiogram can identify patients with nonischemic congestive cardiomyopathy and sustained ventricular arrhythmias.

Entities:  

Mesh:

Year:  1985        PMID: 4064275     DOI: 10.1161/01.cir.72.6.1308

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Prediction of the effectiveness of long-term beta blocker treatment for dilated cardiomyopathy by signal averaged electrocardiography.

Authors:  T Yamada; M Fukunami; T Shimonagata; K Kumagai; J Kim; S Sanada; H Ogita; M Hori; N Hoki
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

2.  Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.

Authors:  Shu Kasama; Takuji Toyama; Yoshiaki Kaneko; Toshiya Iwasaki; Hiroyuki Sumino; Hisao Kumakura; Kazutomo Minami; Shuichi Ichikawa; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-14       Impact factor: 9.236

Review 3.  Utility of SAECG in arrhythmogenic right ventricle dysplasia.

Authors:  Khurram Nasir; Julie Rutberg; Harikrishna Tandri; Ronald Berger; Gordon Tomaselli; Hugh Calkins
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

4.  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.

Authors:  K P Anderson; R Walker; P Urie; P R Ershler; R L Lux; S V Karwandee
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 5.  Prevalence and incidence of arrhythmias and sudden death in heart failure.

Authors:  John G F Cleland; Sudipta Chattopadhyay; Aleem Khand; Timothy Houghton; Gerald C Kaye
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

6.  Multidisciplinary assessment of tako tsubo cardiomyopathy: a prospective case study.

Authors:  Micael Waldenborg; Mona Soholat; Anders Kähäri; Kent Emilsson; Ole Fröbert
Journal:  BMC Cardiovasc Disord       Date:  2011-04-09       Impact factor: 2.298

Review 7.  Signal-averaged electrocardiography: Past, present, and future.

Authors:  Konstantinos A Gatzoulis; Petros Arsenos; Konstantinos Trachanas; Polychronis Dilaveris; Christos Antoniou; Dimitris Tsiachris; Skevos Sideris; Theofilos M Kolettis; Dimitrios Tousoulis
Journal:  J Arrhythm       Date:  2018-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.